Journals / Anadolu Kardiyoloji Dergisi / 2008 / Cilt: 8 - Sayı: 6

Normotansif kan basıncı olan hastalarda sol ventrikül yapı, fonksiyon ve elastisite farklılıkları

Differences in left ventricular structure, functions and elastance in the patients with normotensive blood pressure

Pages
413–421
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Methods: A total of 294 normotensive patients (

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed in this study to investigate the differences in left ventricular (LV) structure, function and elastance parameters in the patients with normotensive blood pressure (BP) levels.
📊
Key Findings & Data:Objective: We aimed in this study to investigate the differences in left ventricular (LV) structure, function and elastance parameters in the patients with normotensive blood pressure (BP) levels.
💡
Conclusion & Impact:Methods: A total of 294 normotensive patients (
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: We aimed in this study to investigate the differences in left ventricular (LV) structure, function and elastance parameters in the patients with normotensive blood pressure (BP) levels. Methods: A total of 294 normotensive patients (

Özet

Amaç: Bu çalışmada normotansif kan basıncı düzeylerine sahip hastalar arasında sol ventrikül yapı, fonksiyon ve elastisite farlılıklarını araştırmayı amaçladık. Yöntemler: Enine-kesitli bu çalışmaya toplam 294 hasta alındı (

🔖

Cite This Article

DOĞRU, M. T., ÇELİK, T., TİRELİ, E., GÜNERİ, M., İYİSOY, A. (2022). Normotansif kan basıncı olan hastalarda sol ventrikül yapı, fonksiyon ve elastisite farklılıkları. Anadolu Kardiyoloji Dergisi, Cilt: 8 - Sayı: 6, 413–421. https://ajindex.com/articles/436987

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Kaplan NM. Systemic hypertension: mechanisms and diagnosis. In: Zipes DP, Libby P, Bonow R, Braunwald E, editors. Braunwald’ Heart Disease. Textbook of Cardiovascular Medicine. 7th.edition. Philadelphia: Elsevier Saunders; 2005; p.959-87
  2. Muscholl MW, Hense HW, Bröckel U, Döring A, Riegger GA, Schunkert H. Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. BMJ 1998; 317: 565-70
  3. Marchesi C, Maresca AM, Solbiati F, Franzetti I, Laurita E, Nicolini E, et al. Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function. J Hypertens 2007; 20: 1079-84
  4. Bing OH, Brooks WW, Robinson KG, Slawsky MT, Hayes JA, Litwin SE, et al. The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol 1995; 27: 383-96
  5. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension: role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 1991; 69: 107-15
  6. Dool JS, Mak AS, Friberg P, Wahlander H, Hawrylechko A, Adams MA. Regional myosin heavy chain expression in volume and pressure overload induced cardiac hypertrophy. Acta Physiol Scand 1995; 155: 396-404
  7. Castellano M, Bohm M. The cardiac beta-adrenoreceptor-mediated signaling pathway and its alterations in hypertensive heart disease. Hypertension 1997; 29: 715-22
  8. Atkins FL, Bing OH, DiMauro PG, Conrad CH, Robinson KG, Brooks WW. Modulation of left and right ventricular beta-adrenergic receptors from spontaneously hypertensive rats with left ventricular hypertrophy and failure. Hypertension 1995; 26: 78-82
  9. Nagata K, Communal C, Lim CC, Jain M, Suter TM, Eberli FR, et al. Altered beta-adrenergic signal transduction in nonfailing hypertrophied myocytes from Dahl salt-sensitive rats. Am J Physiol Heart Circ Physiol 2000; 279: H2502-8
  10. Czarnecka D, Bilo G. A patient with high normal blood pressure-should we treat? Blood Press Suppl 2005; 2: 50-2
  11. Giles TD. Assessment of global risk: a foundation for a new, better definition of hypertension. J Clin Hypertens (Greenwich) 2006; 8 (8 Suppl 2): 5-14
  12. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hyper